You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 20, 2024

Investigational Drug Information for Brilacidin


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Brilacidin?

Brilacidin is an investigational drug.

There have been 4 clinical trials for Brilacidin. The most recent clinical trial was a Phase 2 trial, which was initiated on August 14th 2014.

The most common disease conditions in clinical trials are Stomatitis, Communicable Diseases, and Mucositis. The leading clinical trial sponsors are Innovation Pharmaceuticals, Inc., Cellceutix Corporation, and [disabled in preview].

There are seventeen US patents protecting this investigational drug and four hundred and two international patents.

Recent Clinical Trials for Brilacidin
TitleSponsorPhase
A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19Innovation Pharmaceuticals, Inc.Phase 2
A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy VolunteersInnovation Pharmaceuticals, Inc.Phase 1
Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck CancerCellceutix CorporationPhase 2

See all Brilacidin clinical trials

Clinical Trial Summary for Brilacidin

Top disease conditions for Brilacidin
Top clinical trial sponsors for Brilacidin

See all Brilacidin clinical trials

US Patents for Brilacidin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Brilacidin ⤷  Sign Up Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Sign Up
Brilacidin ⤷  Sign Up Arylamide compounds and compositions and uses thereof Innovation Pharmaceuticals Inc. (Beverly, MA) ⤷  Sign Up
Brilacidin ⤷  Sign Up Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof Redwood Bioscience, Inc. (Emeryville, CA) ⤷  Sign Up
Brilacidin ⤷  Sign Up Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate R.P. Scherer Technologies, LLC (Carson City, NV) ⤷  Sign Up
Brilacidin ⤷  Sign Up Pharmaceutical glass packaging assuring pharmaceutical sterility Corning Incorporated (Corning, NY) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Brilacidin

Drugname Country Document Number Estimated Expiration Related US Patent
Brilacidin Australia AU2017261372 2036-05-05 ⤷  Sign Up
Brilacidin Canada CA3023278 2036-05-05 ⤷  Sign Up
Brilacidin China CN107847398 2036-05-05 ⤷  Sign Up
Brilacidin European Patent Office EP3452003 2036-05-05 ⤷  Sign Up
Brilacidin European Patent Office EP3981392 2036-05-05 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.